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ABSTRACT
High-risk human papillomavirus 31 (HPV31)-positive cells exhibit constitutive activation of the ATM-dependent DNA damage
response (DDR), which is necessary for productive viral replication. In response to DNA double-strand breaks (DSBs), ATM
activation leads to DNA repair through homologous recombination (HR), which requires the principal recombinase protein
Rad51, as well as BRCA1. Previous studies from our lab demonstrated that Rad51 and BRCA1 are expressed at high levels in
HPV31-positive cells and localize to sites of viral replication. These results suggest that HPVmay utilize ATM activity to increase
HR activity as a means to facilitate viral replication. In this study, we demonstrate that high-risk HPV E7 expression alone is suf-
ficient for the increase in Rad51 and BRCA1 protein levels. We have found that this increase occurs, at least in part, at the level of
transcription. Studies analyzing protein stability indicate that HPVmay also protect Rad51 and BRCA1 from turnover, contrib-
uting to the overall increase in cellular levels. We also demonstrate that Rad51 is bound to HPV31 genomes, with binding in-
creasing per viral genome upon productive replication. We have found that depletion of Rad51 and BRCA1, as well as inhibition
of Rad51’s recombinase activity, abrogates productive viral replication upon differentiation. Overall, these results indicate that
Rad51 and BRCA1 are required for the process of HPV31 genome amplification and suggest that productive replication occurs in
a manner dependent upon recombination.
IMPORTANCE
Productive replication of HPV31 requires activation of an ATM-dependent DNA damage response, though how ATM activity
contributes to replication is unclear. Rad51 and BRCA1 play essential roles in repair of double-strand breaks, as well as the re-
start of stalled replication forks through homologous recombination (HR). Given that ATM activity is required to initiate HR
repair, coupled with the requirement of Rad51 and BRCA1 for productive viral replication, our findings suggest that HPVmay
utilize ATM activity to ensure localization of recombination factors to productively replicating viral genomes. The finding that
E7 increases the levels of Rad51 and BRCA1 suggests that E7 contributes to productive replication by providing DNA repair fac-
tors required for viral DNA synthesis. Our studies not only imply a role for recombination in the regulation of productive
HPV replication but provide further insight into how HPV manipulates the DDR to facilitate the productive phase of the
viral life cycle.
Human papillomaviruses (HPVs) are small double-strandedDNA viruses approximately 8 kb in size that exhibit a prefer-
ential tropism for epithelial cells. High-risk mucosal HPV sub-
types are the causative agents of cervical cancer and have been
increasingly associated with anogenital, oropharyngeal, and head
and neck cancers (1). The life cycle of HPV is intimately linked to
the differentiation of its host cell, the keratinocyte (2). After expo-
sure through a microwound in the stratified epithelium, HPV
infects the actively dividing basal cells. Upon infection, viral ge-
nomes are amplified transiently to 50 to 100 copies per cell, which
are subsequently maintained by replicating once per cell cycle,
along with cellular DNA. As infected daughter cells migrate out of
the basal stratum into the suprabasal cell layers to undergo differ-
entiation, expression of viral E7 and E6 proteins prevents the nor-
mal exit from the cell cycle and promotes reentry of infected cells
into S phase, providing a cellular environment conducive for viral
DNA synthesis. Upon differentiation, the productive phase of the
viral life cycle is induced, resulting in amplification of viral ge-
nomes to thousands of copies per cell, late gene expression, and
virion assembly and release from the outermost surface of the
epithelium (3).
Previous studies demonstrated that high-risk HPV31 pro-
motes the constitutive activation of an ATM (ataxia telangiecta-
sia-mutated kinase)-dependent DNA damage response and that
ATM activity is necessary for productive viral replication (4). Ac-
tivation of ATM is instrumental in the cellular response to certain
types of genomic damage, particularly DNA double-strand breaks
(DSBs), one of the most harmful types of DNA lesions if left un-
repaired (5, 6). Phosphorylation of ATM sets in motion signaling
events that temporarily stop progression of the cell cycle, activate
downstream repair factors, and, if necessary, initiate apoptosis
(7). Earlier studies demonstrated that althoughATMkinase activ-
ity is critical for productive amplification of HPV31 genomes,
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episomal maintenance is not affected with inhibition of ATM in
undifferentiated cells (4). These studies suggest that HPV induces
ATM activation specifically for productive replication, although
how HPV utilizes this activity for viral replication is unclear.
Previous studies by our lab and others demonstrated the re-
cruitment of ATM-dependent DNA damage response factors
(H2AX, Chk2, 53BP1, MRN complex [Mre11, Rad50, Nbs1]) to
sites of HPV DNA synthesis (8, 9). Furthermore, increased levels
of the homologous recombination (HR) proteins Rad51 and
BRCA1, as well as their colocalization to sites of viral DNA repli-
cation, were observed (8). Coupled with the detection of the DNA
damage marker H2AX and phosphorylated RPA32, a marker of
DNA damage and/or perturbed replication (10–12), at HPV rep-
lication foci (8), these results suggest that HPV could utilize the
ATMDNA damage response pathway to upregulate, activate, and
recruit DNA repair factors to viral genomes to promote amplifi-
cation through DNA repair mechanisms.
Restoration of proper cellular genomic structure from DNA
double-strand breaks is facilitated through two principal path-
ways of repair that function at different stages of the cell cycle.
Nonhomologous end joining (NHEJ) can occur throughout the
cell cycle, while HR repair is found predominantly in the late S/G2
phase due to the requirement of a sister chromatid as a template
for repair (13). Unlike NHEJ, which is capable of inadvertently
removing large regions of DNA during the repair process, HR is
generally viewed as an error-free system of DNA damage repair.
Central to the HR repair process is the recombinase Rad51. Initial
recognition and resection of DSBs by the MRN complex and the
nuclease CtIP result in coating of single-stranded DNA (ssDNA)
by the tripartite RPA complex (7, 14). RPA is then replaced by
Rad51, resulting in the formation of a Rad51-ssDNA nucleofila-
ment that facilitates strand annealing and invasion of the neigh-
boring homologous template, leading to the displacement of the
identical DNA strand (D-loop) (15).
The tumor suppressor BRCA1 (breast cancer 1, early onset)
functions to maintain genomic stability through the assembly of
multiple protein complexes involved in DNA repair, cell cycle
arrest, and transcriptional regulation (16). BRCA1 is significantly
involved at multiple steps along the HR repair pathway (17). In-
teractions of BRCA1 with the CtIP endonuclease and the MRN
complex are important for the initial processing of DSB ends (18,
19), which stimulates HR repair while repressing NHEJ (20). In
addition, the association of BRCA1 with PALB2 and BRCA2 aids
in the recruitment of Rad51 to sites of DNA damage (21).
Mounting evidence indicates that viruses exploit the cellular
DNAdamage response in order to facilitate the replication of their
own geneticmaterial (22, 23), and recombination-dependent rep-
lication has been previously described as a viable and efficient
method for production for some virus types (24). In fact, DNA
viruses such as simian virus 40 (SV40) (25), herpes simplex virus 1
(HSV-1) (26–28), Epstein-Barr virus (EBV) (29, 30), andKaposi’s
sarcoma-associated herpesvirus (KSHV) (31) have exhibited the
use of replication-associated recombination in the synthesis of
their genomes during infection. We recently demonstrated the
importance of members of the DNA double-strand break recog-
nition complex, MRN, in the HPV productive life cycle (32).
MRN facilitates the activation of ATM in response to DSBs and
also functions downstream of ATM to facilitate HR repair, as
mentioned above.We found that disruption of theMRN complex
through depletion of Nbs1 abrogates productive replication of
HPV31 and blocks the recruitment ofMre11 and Rad50, as well as
Rad51, to viral genomes (32). Given the importance of ATM, the
MRN complex, Rad51, and BRCA1 to DSB repair through HR,
these results suggest that recombination may play a role in the
amplification of HPV genomes.
In this work, we investigate the mechanisms by which Rad51
and BRCA1 are regulated inHPV-infected cells, as well as whether
they contribute to viral replication throughout the life cycle. We
have found that E7 expression alone is sufficient to increase the
protein levels of Rad51 and BRCA1. Importantly, we have dem-
onstrated that Rad51 binds to HPV31 genomes, with binding per
genome increasing during productive replication. Knockdown of
Rad51 and BRCA1, as well as inhibition of Rad51 activity using a
small-molecule inhibitor, is sufficient to block productive replica-
tion but not viral genome maintenance, similarly to previously
published studies after loss of ATM and MRN activity (4, 32).
Overall, these studies indicate that HPVmay utilize ATM activity
to facilitate recombination at viral genomes through Rad51 and
BRCA1.
MATERIALS AND METHODS
Cell culture. Primary human foreskin keratinocytes (HFKs) were isolated
from neonatal foreskins as previously described and cultured in Der-
maLife keratinocyte growth medium (KGM; Lifeline Cell Technology)
(33). CIN612 9E, HFK-31, HFK31-E6, HFK31-E7, HFK31-E6E7, and
HFK31/DR-GFP cells were cultured in E medium supplemented with 5
ng/ml mouse epidermal growth factor (EGF; BD Biosciences) in the pres-
ence of mitomycin C-treated J2 3T3 fibroblast feeder cells, as described
previously (33). 293T cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM; Life Technologies) supplemented with 10% bovine
growth serum (BGS; ThermoFisher Scientific). When necessary, J2 feed-
ers were removed from HPV-positive cells by incubation with 1 mM
EDTA in phosphate-buffered saline (PBS).
Plasmids and chemicals. The HPV31 E6-, HPV31 E7-, and HPV31
E6E7-pLSXN vectors have been previously described (34). The pBR322-
HPV31 plasmid containing the wild-type HPV31 genome has been pre-
viously described (34, 35). The p1203 PML2dHPV16 plasmid containing
the wild-type HPV16 genome was obtained from Addgene (plasmid no.
10869). The homologous recombination reporter vector pHPRT-DRGFP
was previously described (36) and obtained from Addgene (plasmid no.
26476). The pHFUW-ISceI lentiviral plasmid was a kind gift from David
M.Weinstock and has been described previously (37). Luciferase reporter
constructs containing the wild-type proximal promoter of Rad51 or
BRCA1 directly upstream of the firefly luciferase gene have been previ-
ously described and were a kind gift from Peter M. Glazer (38, 39). The
promoterless pGL3-basic andpRL-SV40 (Renilla luciferase) reporter con-
structs were obtained fromPromega. B02was obtained fromCalbiochem.
Generation of HPV31- and HPV16-positive HFKs. HFKs stably
maintaining HPV31 and HPV16 genomes were created as described pre-
viously (33). Briefly, the HPV31 and HPV16 genomes were excised from
plasmid backbones using HindIII and BamHI, respectively. Excised ge-
nomes were religated using T4 DNA ligase (Life Technologies). Primary
HFKs were transfected with 1g of ligatedHPV genomes along with 1g
of pSV2-Neo using FuGene 6 per the manufacturer’s instructions (Pro-
mega). Stable transfectants were generated through 8 days of G418 selec-
tion (Sigma), and surviving populations were pooled and expanded for
analysis.
Differentiationof keratinocytes.For differentiation, 1.5%methylcel-
lulose was used as described previously (33). Cells were harvested at 0 h,
during log-phase growth (undifferentiated), as well as 24 and 48 h after
suspension in methylcellulose. High-calcium medium was also used to
induce differentiation, as previously described (4). Subconfluent cells
were harvested as at T0, and the remaining plates of cells were serum
starved overnight in basal keratinocyte growth medium (KGM; Lonza)
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with supplements for 16 h. Cells were then incubated in keratinocyte basal
medium (KBM; Lonza) without supplements but with 1.8 mM CaCl2
(Sigma). Cells were allowed to differentiate for 48, 72, or 96 h after addi-
tion of high-calcium medium. DNA and protein were harvested at each
time point, and viral genome amplification was measured by Southern
blotting for each experiment to ensure activation of the productive phase
of the viral life cycle.
Luciferase assays. HFK or CIN612 9E cells (1  105) were seeded in
6-well plates. The next day, cells were transfected in triplicate with 500 ng
of either pGL3-basic, Rad51WT-luc, or BRCA1WT-luc reporter plasmids
along with 100 ng of the Renilla-luc plasmid (Promega) using polyethyl-
eneimine (PEI) in Opti-MEM (Gibco). Sixteen hours later, transfection
medium was replaced with fresh KGM for HFKs and E medium for
CIN612 cells. Seventy-two hours later, cells were harvested using 1 pas-
sive lysis buffer per themanufacturer’s instructions (Promega). Luciferase
activity was determined using the Dual-Glo substrate kit per the manu-
facturer’s instructions (Promega), and samples were read on the LMax
luminometer (Molecular Devices) with parameters of a 2-s delay followed
by a 10-s read. Promoter activity was determined by normalizing firefly
luciferase activity to Renilla luciferase activity and calculating the fold
change over pGL3-basic control values.
Lentivirus production. Lentivirus was produced as previously de-
scribed (40). Plasmids carrying the short hairpin RNA (shRNA) se-
quences for Rad51 (TRCN0000018876 and TRCN0000018879) or
BRCA1 (TRCN0000009824 and TRCN0000039833) or a scramble non-
target control shRNA cloned into the pLKO.1-puro background were
obtained from the UNC Lentiviral Core Facility (Chapel Hill, NC). Each
of these plasmids (5 g) was transiently transfected into 293T cells, along
with 3.37 g Gag-Pol-Tet-Rev plasmid DNA and 1.66 g vesicular sto-
matitis virus G (VSV-G) plasmid DNA using polyethyleneimine (PEI)
(VWR). Supernatants containing lentivirus were harvested 72 h post-
transfection, sterile filtered, and stored at80°C until used. I-SceI lenti-
virus was packaged according to the same procedure. CIN612 9E and
HFK-31 cells were transduced with 5 ml viral supernatant in the presence
of 4.8 g/ml hexadimethrine bromide (Polybrene) (Sigma-Aldrich).
Southern blot analysis.DNA was isolated and Southern blot analysis
was performed as described previously (41). Briefly, cells were harvested
in buffer containing 400 mM NaCl, 10 mM Tris (pH 7.5), and 10 mM
EDTA. Cells were lysed by the addition of 30 l of 20% SDS and subse-
quently treated with 15 l of 10-mg/ml proteinase K overnight at 37°C.
DNA was then extracted with phenol chloroform and precipitated using
sodium acetate and ethanol. Five micrograms of resultant DNA was di-
gested with BamHI (which does not cut the HPV31 genome) or HindIII
(which linearizes the HPV31 genome) (New England BioLabs), separated
on an 0.8% agarose gel for 15 h at 40 V, and subsequently transferred to a
positively charged nylon membrane (Immobilon-Ny; Millipore). 32P-
labeled linearized HPV31 genome was used as a probe.
Western blot analysis.Whole-cell lysates were prepared by lysing cell
pellets in radioimmunoprecipitation assay (RIPA) buffer supplemented
with Complete Mini protease inhibitor and PhosSTOP phosphatase in-
hibitor tablets (Roche). Total cellular protein concentrations were deter-
mined by the Bio-Rad protein assay (Bio-Rad). Equal amounts of total
cellular protein were separated via SDS-PAGE and subsequently trans-
ferred to polyvinylidene difluoride (PVDF) membranes (Immobilon-P;
Millipore). Proteins were visualized using primary antibodies as fol-
lows: Rad51, involucrin, glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (Santa Cruz); BRCA1 (Calbiochem); cleaved caspase-7
D198, caspase-7 (Cell Signaling Technology); phospho-ATM S1981 (Ab-
cam); ATM (Bethyl Laboratories). Secondary antibodies were as follows:
horseradish peroxidase (HRP)-conjugated anti-rabbit (Cell Signaling
Technology) andHRP-conjugated anti-mouse (GE Life Sciences). Clarity
Western enhanced chemiluminescence (ECL) blotting substrate (Bio-
Rad) was used to detect antibody binding.
Cell cycle analysis. CIN612 9E cells transduced with shRNAs for
Scramble, Rad51, or BRCA1 were harvested as at T0 or suspended in
methylcellulose to induce differentiation. At the indicated time points,
cells were fixed in 70% ice-cold ethanol and stored at 4°C overnight. The
next day, cells were washed once with 1 PBS (Gibco), suspended in 1
PBS containing 10 g/ml RNase A and 20 g/ml propidium iodide, and
incubated for 20 min at 37°C. Stained cells were analyzed for total DNA
content using theCyAn (BeckmanCoulter Inc.) flow cytometer. Cell cycle
profiles were visualized, and percent values were calculated using FlowJo
software v10.0.7 (FlowJo).
qPCR analysis. Total cellular RNA was isolated from HFKs and
HFK-31 andCIN612 9E cells, as well asHFK-E6,HFK-E7, andHFK-E6E7
cells using RNA Stat 60 (Tel-Test) followed byDNase digestion according
to the manufacturer’s instructions (Promega). cDNA was generated by
reverse transcription using the iScript reverse transcription kit per the
manufacturer’s instructions (Bio-Rad). Fifty nanograms of cDNA was
analyzed in triplicate reactions using quantitative PCR (qPCR) with 375
nMprimers and iTaqUniversal SYBRgreen Supermix (Bio-Rad) in a total
reaction volume of 20 l. Reactions were carried out in an Applied Bio-
systems QuantStudio 6 Flex real-time PCR thermal cycler (Life Technol-
ogies). Reaction profiles were set up as follows: initial denaturation at
95°C for 10min followed by 40 cycles of 95°C for 15 s, 63°C for 1min, and
72°C for 30 s. Melt curves were subsequently performed to ensure proper
primer annealing. Relative transcript amounts were calculated using the
threshold cycle method (CT) with GAPDH as the reference gene and
normalized to uninfected HFK samples. Gene-specific primers were as
follows: Rad51 forward, 5=-TCTCTGGCAGTGATGTCCTGGA-3=;
Rad51 reverse, 5=-TAAAGGGCGGTGGCACTGTCTA-3=; BRCA1 for-
ward, 5=-CTGAAGACTGCTCAGGGCTATC-3=; BRCA1 reverse, 5=-AG
GGTAGCTGTTAGAAGGCTGG-3=; GAPDH forward, 5=-CTGTTGCT
GTAGCCAAATTCGT-3=; GAPDHreverse, 5=-ACCCACTCCTCCACCT
TTGAC-3=.
Measurement of protein half-life.HFK or CIN612 9E cells (2 105)
(plus J2 feeders) were seeded in 60-mm dishes. Forty-eight hours later,
one culture dish was harvested for the 0-h point and the rest of the culture
dishes were treated with 50 g/ml cycloheximide (Sigma-Aldrich). Cells
were harvested for total cellular protein at 2, 4, 6, 8, 12, and 24 h after
cycloheximide addition. At harvest, 3T3-J2 feeder cells were removedwith
Versene prior to harvesting of CIN612 cells. Western blot analysis was
performed as described above using 100g of lysate fromHFKs and 50g
of lysates from CIN612 cells.
ChIP. At the indicated time points, CIN612 cells were cross-linked
with 1% formaldehyde at 37°C for 10 min, subsequently quenched with
0.125 M glycine, and centrifuged at 240 g for 4 min at room tempera-
ture. Cells were washed with 1 PBS and permeabilized in cell lysis buffer
(10mMEDTA, pH8.0, 0.5mMEGTA, 10mMHEPES, pH6.5, 1%Triton
X-100, 1% NP-40) on ice for 10 min. Cells were washed in wash buffer
(pH8.0; 0.5mMEGTA, 10mMHEPES, pH6.5), resuspended in 500l of
sonication buffer (10 mM Tris, pH 8, 100 mM NaCl, 1 mM EDTA, 0.5
mM EGTA, 0.1% sodium deoxycholate, 0.5% N-lauroylsarcosine) sup-
plemented with 1 protease inhibitor cocktail (PIC) (Roche) and 1 mM
phenylmethylsulfonyl fluoride (PMSF), and incubated for 20 min on ice.
Sonicationwas performedwith a Bioruptor-300 at 22 cycles of 30 s on and
30 s off. Four hundredmicrograms of cleared chromatin was subjected to
immunoprecipitation overnight with 10g of Rad51 (Santa Cruz) or IgG
antibodies. One percent of the sample used for immunoprecipitation was
saved as the input. The next day, samples were incubated with 25 l of
Protein AG UltraLink resin beads (Thermo Scientific). The beads were
washed for 2 min with the following buffers: low-salt wash buffer (0.1%
SDS, 1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris [pH
8.1]) with 1 PIC freshly added, high-salt wash buffer (0.1% SDS, 1%
Triton X-100, 2 mM EDTA, 500 mM NaCl, 20 mM Tris [pH 8.1]), LiCl
wash buffer (0.25 M LiCl, 1% NP-40, 1% deoxycholate, 1 mM EDTA, 10
mM Tris [pH 8.1]), and two TE buffer (10 mM Tris [pH 8.1] and 1 mM
EDTA) washes. DNA was eluted from the beads with 200 l of elution
buffer (1% SDS, 0.1MNaHCO3) followed by reverse cross-linking with 4
l of 5MNaCl and 1l of RNase A (Sigma) incubated overnight at 65°C.
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Input chromatin was also subjected to similar treatment to reverse cross-
link. DNA was harvested after proteinase K digestion using spin columns
(Qiagen) and eluted with water. Input and immunoprecipitated DNAs
were assayed in triplicate reactions by quantitative PCR (qPCR) in an
Applied Biosystems QuantStudio 6 Flex real-time PCR thermal cycler
(Life Technologies). Reaction profiles were set up as follows: initial dena-
turation at 95°C for 10min followed by 40 cycles of 95°C for 15 s, 63°C for
1 min, and 72°C for 30 s. Melt curves were subsequently performed to
ensure proper primer annealing. The following primer pairs specific to the
HPV31 upstream regulatory region (URR) (bp 7708 to 7784) were used
for qPCR: forward primer 5= TCCTACACACCTTAAACTGCTTTTAGG
3= and reverse primer 5= GCAAAAGCCAGCACTGCAATC 3=. Chroma-
tin immunoprecipitation (ChIP) signals were represented as a percentage
of input chromatin calculated by normalization against signals of nonspe-
cific IgG.
Homologous recombination reporter assay.To generate theHFK31/
DR-GFP cell line, the DR-GFP fragment was isolated from the pHPRT-
DRGFP plasmid by digestion with SacI and KpnI (New England BioLabs)
and subsequent gel purification. One microgram of isolated DR-GFP
fragment was transfected into HFK-31 cells using FuGene 6 per the man-
ufacturer’s instructions (Promega), followed by stable selection using pu-
romycin (Sigma) and 6-thioguanine (Sigma) as previously described (36).
Surviving populations were pooled and expanded for analysis. For analy-
sis of homologous recombination activity, 2 105 HFK31/DR-GFP cells
were plated onto 100-mm tissue culture dishes seeded with mitomycin
C-treated 3T3-J2 feeder cells in E medium supplemented with EGF. The
following day, cells were transducedwith I-SceI viral supernatant for 16 h.
After transduction, viral supernatant was replaced with fresh E medium
and mitomycin C-treated 3T3-J2 feeder cells on each culture plate. B02
was added to respective plates with the medium change, and plates were
incubated at 37°C for 72 h. At harvest, feeder cells were removed using
EDTA-PBS (Versene) and HFK31/DR-GFP cells were removed using
trypsin and pelleted. Cells were then fixed in 3% paraformaldehyde
(Sigma), analyzed on aCyAn (BeckmanCoulter Inc.) flow cytometer, and
visualized using Flowing software v2.5.1 (University of Turku, Finland)
for percent green fluorescent protein (GFP) expression. Homologous re-
pair frequencies were calculated by subtracting the percentage of cells
expressingGFP fromnonspecific homologous recombination events (i.e.,
without I-SceI virus treatment) and then determining percent GFP ex-
pression relative to I-SceI virus-treated cells without B02.
RESULTS
Homologous recombination factors Rad51 and BRCA1 are in-
creased inHPV-positive cells. Previous studies by our laboratory
demonstrated that HPV31-positive CIN612 9E (referred to as
CIN612) keratinocytes, which are derived from a cervical intra-
epithelial neoplasia grade 1 (CIN1) lesion, exhibit increased pro-
tein levels of the homologous recombination factors Rad51 and
BRCA1 compared to uninfected keratinocytes derived from neo-
natal human foreskins (HFKs) (8). We also found that Rad51 and
BRCA1 colocalize to sites of viral replication in undifferentiated
cells, as well as to sites of productive viral replication upon differ-
entiation, indicating that HPVmay increase levels of these factors
to drive viral replication. To determine if HPV31 lines generated
in the laboratory exhibit a similar increase in Rad51 and BRCA1
protein levels, HFKs were transfected with either recircularized
HPV31 (HFK-31) or HPV16 (HFK-16) genomes, along with a
neomycin resistance cassette. Stable lines were generated through
selection in neomycin. Similar to CIN612 cells, HFK-31 as well as
HFK-16 cells exhibited increasedRad51 andBRCA1 protein levels
compared to uninfectedHFKs, across multiple HFK backgrounds
(Fig. 1A). As shown in Fig. 1B, BRCA1 levels were similar between
CIN612 and HFK-31 cells and were significantly increased over
FIG 1 High-risk HPV-positive keratinocytes exhibit higher levels of Rad51
and BRCA1 proteins in an E7-dependent manner. (A)Whole-cell lysates were
isolated from uninfected primary human foreskin keratinocytes (HFKs) and
CIN612 9E cells, as well as HFKs stably maintaining HPV31 (HFK-31) or
HPV16 (HFK-16) genomes. Immunoblotting was performed using antibodies
specific to Rad51 and BRCA1, with GAPDH serving as a loading control. (B)
Densitometry was performed across at least three independent experiments
examining Rad51 and BRCA1 protein levels by immunoblotting in HFKs and
CIN612 and HFK-31 cells using ImageJ software. Protein levels were normal-
ized to the GAPDH loading control. Error bars represent means  standard
errors. *,P	 0.05; **,P	 0.01. (C)Western blot analysis of Rad51 andBRCA1
protein levels in whole-cell lysates from HFKs stably transduced with HPV31
E6-, E7-, or E6/E7-expressing retroviral vectors. Tubulin was used as a loading
control. Densitometry was performed across at least four independent exper-
iments using ImageJ software. Protein levels were normalized to the respective
loading control. Error bars represent means standard errors. *, P	 0.05; **,
P 	 0.01; N.S., not significant. (D) Whole-cell lysates were harvested from
control HFKs as well as HFKs stably expressing HPV31 E7 or E6/E7 at T0
(undifferentiated) or after differentiation in methylcellulose (24 and 48 h).
Western blot analysis was performed using antibodies to Rad51 and BRCA1
with GAPDH as a loading control. Densitometry was performed using ImageJ
software. Protein levels were normalized to the GAPDH loading control. Den-
sitometry was performed across at least four independent experiments. Error
bars represent means standard errors. *, P	 0.05; **, P	 0.01.
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those in HFKs. AlthoughHFK-31 and CIN612 cells also exhibited
a significant increase in Rad51 protein levels (Fig. 1B), CIN612
cells consistently displayed higher levels of Rad51 than did
HFK-31 cells. While we did observe some variation in Rad51 and
BRCA1 protein levels between different HFK backgrounds,
HPV31-positive cells (CIN612 and HFK-31) consistently exhib-
ited significantly higher levels of Rad51 and BRCA1 protein, re-
gardless of the background utilized (Fig. 1B).
A recent study by Park et al. demonstrated that expression of
HPV16 E7 in oral keratinocytes is sufficient to increase protein
levels of Rad51 (42). To determine if HPV31 E7 is also capable of
increasing the levels of Rad51, as well as BRCA1, we examined
HFKs retrovirally transduced and stably expressing HPV31 E6,
E7, or E6/E7 in combination. As shown in Fig. 1C, expression of
E7 alone was sufficient to significantly increase protein levels of
Rad51 and BRCA1 compared to HFKs, as well as E6-expressing
cells, and this effect was maintained in E6/E7-expressing cells. In
contrast, Rad51 and BRCA1 levels in E6-expressing cells were on
average more similar to those found in HFKs (Fig. 1C). As shown
in Fig. 1D, levels of Rad51 andBRCA1weremaintained in E7- and
E6/E7-expressing cells upon differentiation induced by suspen-
sion in methylcellulose, which is commonly used to study the
productive phase of the viral life cycle. Similar results were ob-
served with HFKs expressing HPV16 E7 (data not shown). These
results suggest that E7 is a key factor in maintaining the increased
Rad51 and BRCA1 levels observed in HPV-positive cells.
HPV31-positive cells exhibit increased transcript levels of
Rad51 and BRCA1. Our studies demonstrate that HPV31-posi-
tive cellsmaintain elevated levels of Rad51 andBRCA1protein. To
determine if HPV regulates Rad51 and BRCA1 at the level of tran-
scription, we first examined the promoter activity of Rad51 and
BRCA1using a luciferase reporter system. Expression vectors con-
taining the proximal promoter sequence of either Rad51 or
BRCA1 directly upstream of the firefly luciferase gene were tran-
siently transfected into undifferentiated HFKs or HPV31-positive
CIN612 cells. Forty-eight hours posttransfection, cells were har-
vested and luciferase activity was measured. As shown in Fig. 2A,
the promoter activity of Rad51 and BRCA1 was significantly
higher in CIN612 cells than in uninfected cells, exhibiting an ap-
proximately 7.5-fold increase in Rad51 promoter activity and an
approximately 9-fold increase in BRCA1 promoter activity. These
results suggest that HPV31 may increase Rad51 and BRCA1 pro-
tein levels through increased transcription.
To examine whether increased promoter activity correlated
with increased transcription, we examined Rad51 and BRCA1
mRNA levels in CIN612 cells compared toHFKs. As shown in Fig.
2B, CIN612 cells exhibited a significant increase in transcript lev-
els of Rad51 and BRCA1 compared to uninfected HFKs, across
multiple HFK backgrounds. Rad51 and BRCA1 transcript levels
were also significantly increased in HFK-31 cells compared to the
matched HFKs, across several HFK backgrounds (Fig. 2C). To
determine if these results could be attributed to the expression of
E7, we examined Rad51 and BRCA1 message levels in the HPV31
E6, E7, and E6/E7HFK lines. As shown in Fig. 2D, transcript levels
of Rad51 and BRCA1 significantly increased upon expression of
E7, as well as E6/E7 in combination, compared to HFKs, as well as
E6-expressing cells. Interestingly, despite similar levels of Rad51
and BRCA1 protein being observed in E6-expressing cells com-
pared to HFKs (Fig. 1B), the mRNA levels of Rad51 and BRCA1
were significantly increased compared to the HFK control
(Fig. 2D). This observation suggests the possibility that the regu-
lation of Rad51 and BRCA1 levels in HPV31-positive cells is not
due simply to increased transcript levels.
HPV31 increases the half-life of Rad51 and BRCA1 proteins.
The expression of E7 is well known to lead to the degradation of
key cellular proteins necessary for progression of the viral life cycle
(i.e., Rb, p107, and p130); however, other proteins have been re-
ported to have increased half-lives due to the presence of E7 (i.e.,
p53) (43). E6 is best known for targeting proteins for degradation
(i.e., p53, BAX, and PDZ domain-containing proteins) through
interaction with the E6AP ubiquitin ligase (44). To determine if
HPV31 has an effect on the half-life of Rad51 and BRCA1, we
inhibited de novo protein synthesis by treating HFKs and CIN612
cells with cycloheximide for the indicated times (Fig. 3). As shown
in Fig. 3, the half-lives of both Rad51 and BRCA1 proteins were
significantly extended in CIN612 cells compared to HFKs, across
multiple HFK backgrounds. These data support the possibility
that Rad51 and BRCA1 are regulated in a transcriptional as well as
posttranscriptional manner. The finding that E7 expression sig-
nificantly increases protein levels of Rad51 and BRCA1 while E6
does not suggests that E7 may impart an additional level of regu-
lation through enhancing protein stability.
Rad51 and BRCA1 are required for productive viral replica-
tion. The increase in Rad51 and BRCA1 in HPV31-positive cells
and their localization to viral replication foci suggest that theymay
be important for viral replication. To test this, we utilized small
hairpin RNAs (shRNAs) containing a control sequence (Scram-
ble; shScram) or sequences that target Rad51 (shRad51) or
BRCA1 (shBRCA1). The efficiency of Rad51 and BRCA1 knock-
down is shown in Fig. 4A. We first examined the effect of tran-
siently knocking down Rad51 and BRCA1 expression on the abil-
ity of viral episomes to be maintained in undifferentiated cells.
CIN612 cells were left untreated or were transduced with lentivi-
rus particles containing a scramble control shRNA (shScram),
Rad51 shRNA #1, or BRCA1 shRNA #1 (Fig. 4B). Since stable
knockdown of Rad51 and BRCA1 proved to be toxic to HPV31-
positive cells, we analyzed episome copy number 4 days posttrans-
duction. Despite localization to viral genomes, transient knock-
down of Rad51 or BRCA1 had little to no effect on the ability of
viral episomes to be maintained (Fig. 4B). To determine if Rad51
and BRCA1 were required for productive replication upon differ-
entiation, CIN612 cells were left untreated or transduced with
lentiviruses containing shScram, shRad51, or shBRCA1. Forty-
eight hours posttransduction, undifferentiated cells were either
harvested (T0) or differentiated in methylcellulose for 24 and 48 h
to activate the productive phase of the viral life cycle (Fig. 4C and
D). As shown in Fig. 4C, while knockdown of Rad51 had no de-
tectable effect on episome maintenance in undifferentiated cells,
productive replication was significantly decreased upon differen-
tiation. Similarly, knockdown of BRCA1 did not affect episome
copy number in undifferentiated cells, while productive replica-
tion was significantly decreased upon differentiation (Fig. 4D).
These results were confirmed using a second shRNA to target
Rad51 and BRCA1 (data not shown). Importantly, levels of the
differentiation-specific marker involucrin were not affected by
knockdown of Rad51 and BRCA1, indicating that the defect in
viral genome amplification was not an indirect effect of blocking
cellular differentiation (Fig. 4C and D). Overall, these results in-
dicate that Rad51 and BRCA1 are required for productive replica-
tion, potentially throughmediatingHR at sites of viral replication.
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HPV requires infected cells to be maintained in a G2/M-like
phase upon differentiation in order to properly amplify viral DNA
and produce infectious virions (45). In addition to DNA repair
through HR, BRCA1 is important in regulating cell cycle check-
points in response to DNA damage (16). To ensure that the block
in productive replication observed with BRCA1 as well as Rad51
knockdown was not due to an effect on the cell cycle, we analyzed
DNA content by flow cytometry. As shown in Fig. 5, untreated
CIN612 cells, as well as CIN612 cells expressing shScram, exhib-
ited a shift in the cell cycle to the G2/M peak upon differentiation
in methylcellulose. However, knockdown of Rad51 and BRCA1
hadno significant effect on theG2/M shift compared to the Scram-
ble control after 24 or 48 h of differentiation in methylcellulose
(P 
 0.05). These results indicate that the lack of viral genome
amplification observed in CIN612-shRad51 and CIN612-sh-
BRCA1 cells is not due to an indirect effect on the cell cycle and
further suggest a direct role for these factors in facilitating viral
replication.
Inhibition of Rad51 function prevents productive viral rep-
lication. The ability of Rad51 to bind single-stranded DNA
(ssDNA) is central to its role in HR (46). Single-stranded DNA
is generated by resection of DSBs or by stalled replication forks,
resulting in the binding of the tripartite RPA complex. RPA is
ultimately replaced by Rad51, which forms nucleofilaments that
mediate strand invasion into homologous sequences. We previ-
ously demonstrated that the RPA32 subunit localizes to HPV31
genomes (8), suggesting that resection occurs on viral DNA. In
addition, RPA32 is phosphorylated on Ser33 at viral genomes
upon differentiation, indicative of DNA damage and/or replica-
tion perturbation (10–12). To determine if Rad51 is bound to viral
DNA, rather than just localized to sites of HPV replication, we
performed chromatin immunoprecipitation (ChIP) analysis on
CIN612 cells that were undifferentiated or differentiated in high-
calcium medium for 72 h to induce the productive phase of the
viral life cycle. As shown in Fig. 6A, we found that Rad51 is bound
to the upstream regulatory region (URR) of HPV31 genomes in
FIG 2 Rad51 and BRCA1 promoter activity and transcript levels are increased in HPV31-positive cells. (A) HFKs and HPV31-positive CIN612 cells were
transiently transfected with luciferase reporter constructs containing either Rad51 or BRCA1 proximal promoter sequences, along with a Renilla luciferase-
expressing control vector. Luciferase assayswere performed 72hposttransfection. Luciferase activitywas normalized toRenilla luciferase activity, and valueswere
calculated as fold change over luciferase activity in uninfected HFKs. Values are averages from five independent experiments standard errors of the means. *,
P  0.03. (B and C) RNA was extracted from uninfected HFKs (B and C), HPV31-positive CIN612 cells (B), and HFK-31 cells (C). Quantitative reverse
transcription-PCR analysis was performed using primers specific to Rad51 and BRCA1. Fold change was calculated using the 2CTmethod. Shown is the fold
change in message levels relative to that in uninfected HFKs, which is set to 1. Values are averages from five independent experiments standard errors of the
means. *, P 0.003; **, P 0.0003. (D)Quantitative reverse transcription-PCRwas used to examine transcript levels of Rad51 and BRCA1 in primaryHFKs and
HFKs that stably express HPV31 E6, E7, or E6/E7. Expression levels are shown relative to uninfected HFKs and were calculated using GAPDH as the reference
gene. Shown is the relative fold change in gene expression over seven independent experiments, across three HFK backgrounds. Data are means  standard
errors. *, P 0.02; **, P 0.01.
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undifferentiated cells. Interestingly, upon differentiation, Rad51
binding to HPV DNA increased per viral genome, suggesting the
formation of Rad51 nucleofilaments. To confirm the importance
of Rad51 activity in productive viral replication, we utilized the
Rad51-specific small-molecule inhibitor B02, which blocks Rad51
binding to DNA and inhibits DNA strand exchange into homol-
ogous sequences (47, 48). As demonstrated in Fig. 6B, CIN612
cells differentiated for 72 h in high-calcium medium with di-
methyl sulfoxide (DMSO) resulted in amplification of viral ge-
nomes, consistent with activation of productive replication.How-
ever, treatment of CIN612 cells with increasing concentrations of
B02 resulted in a significant dose-dependent decrease in viral ge-
nome amplification (Fig. 6B and C). B02 treatment did not affect
the levels of Rad51 until the highest concentration (30 M) (Fig.
6B), which correspondedwith an increase in cellular toxicity (data
not shown). Similarly to knockdownofRad51 protein levels, there
was no appreciable effect on the differentiation-specific marker
involucrin upon treatment with B02 (Fig. 6B), indicating that dif-
ferentiation was not affected. In addition, we also measured the
effect of B02 treatment on the productive replication of HFKs
stably maintaining HPV31 genomes (HFK-31) upon differentia-
tion in high-calcium medium (Fig. 7). Similarly to treatment of
CIN612 cells, a dose-dependent effect on productive replication
was also observed in HFK-31 cells upon exposure to increasing
concentrations of B02 (Fig. 7A andB). To confirm thatHRactivity
is targeted by B02 treatment, we utilized HFK-31 cells containing
a chromosomally integrated HR reporter (DR-GFP), which mea-
sures the efficiency of recombination of two GFP alleles after gen-
eration of a double-strand break by the I-SceI restriction enzyme
(Fig. 7C). As shown in Fig. 7D, treatment of HFK-31 cells with
increasing concentrations of B02 resulted in a dose-dependent
decrease inHR activity. These results further support the idea that
the ability of Rad51 to bind viralDNAand formnucleofilaments is
important for efficient viral genome synthesis. Overall, our find-
ings indicate that HPV increases levels of Rad51 and BRCA1 to
drive HR at viral genomes for efficient DNA synthesis upon dif-
ferentiation.
DISCUSSION
The importance of Rad51 and BRCA1 in homologous recombi-
nation is well established (7, 17). Rad51 is central to recombina-
tion through its ability to coat single-stranded DNA (ssDNA) and
catalyze homologous pairing and strand exchange (46). BRCA1
functions in two distinct steps in HR repair: (i) 5=-3= resection of
DSBs to generate 3= overhangs and (ii) interaction with the
PALB2-BRCA2 complex to load Rad51 onto resected ssDNA. In
this study, we have found that Rad51 is bound to HPV genomes
and that binding per viral genome increases upon differentiation.
These results suggest that extensive resection occurs on viral DNA
during productive replication, prompting Rad51 nucleofilament
assembly, an early step in HR. In support of this, use of an inhib-
itor that blocks Rad51 binding to DNA abrogated productive rep-
lication. In addition toDNA repair, BRCA1 is involved inmultiple
cellular functions, including transcription and cell cycle check-
FIG 3 The half-life of Rad51 and BRCA1 protein is extended in HPV31-positive cells. (A) Uninfected HFKs andHPV31-positive CIN612 cells were treated with
50 g/ml cycloheximide (CHX) over a period of 24 h. Whole-cell lysates were prepared at the indicated time points, and Western blot analysis was performed
using antibodies to Rad51 and BRCA1. GAPDH served as a loading control. One hundredmicrograms of protein was used for theHFK samples, while 50g was
used for the CIN612 cells. (B) Graphed are the relative protein levels at each time point, with T0 values for HFK and CIN612 cells each set to 100. Densitometry
was performed across nine independent experiments using ImageJ software. Protein levels were normalized to the respective GAPDH loading control. Error bars
represent means standard errors. *, P 0.05; **, P 0.01. Results were confirmed through digital imaging ofWestern blots using the Bio-Rad ChemiDocMP
system. Densitometry was performed using Image Lab software (data not shown).
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point activation (16). However, no significant effects on the cell
cycle were observed upon BRCA1 or Rad51 knockdown. The lo-
calization of BRCA1 to HPV replication foci, coupled with the
binding of Rad51 to viral genomes and the requirement for
BRCA1 and Rad51 in productive replication, supports a role for
BRCA1 and Rad51 in facilitating recombination at HPV genomes
during productive replication.
Recombination can be stimulated by resection of DSBs, as
well as ssDNA generated by replication fork stalling, although
how HPV utilizes recombination pathways for replication is
unclear. Productive replication results in viral genome ampli-
fication to thousands of copies per cell, and DSBs could result if
replication proceeds through a nick or gap in the viral DNA.
Indeed, the localization of multiple effectors of the ATM-de-
pendent DNA damage response to viral DNA foci suggests that
DNA lesions form that may stimulate recombination for repair
FIG 4 Knockdown of Rad51 and BRCA1 decreases HPV31 genome amplification upon differentiation. (A) HPV31-positive CIN612 cells were transduced with
lentivirus containing control scramble shRNA sequences (scScram) or two shRNA sequences for Rad51 (shRad51) or BRCA1 (shBRCA1) to analyze efficiency
of knockdown. Western blot analysis was performed using antibodies to Rad51 and BRCA1. GAPDH served as a loading control. (B) CIN612 cells were
transduced with shScram, shRad51 #1, or shBRCA1 #1 and grown as a monolayer for 96 h. DNA was harvested at the indicated times, digested with BamHI
(noncutter) or HindIII (which linearizes the viral genome), and examined by Southern blotting for changes in viral episome levels using the HPV31 genome as
a probe. (C andD)CIN612 cells were left untreated (UT) or transiently transducedwith lentivirus particles containing a control shRNA(shScram), Rad51 shRNA
#1, or BRCA1 shRNA#1 for 48 h. At this time, eitherDNAandproteinwere harvested as aT0 (undifferentiated) sample or cells were suspended inmethylcellulose
to induce differentiation for 24 and 48 h. DNA harvested at each time point was analyzed by Southern blotting using the HPV31 genome as a probe. Whole-cell
lysates harvested at the indicated time points were analyzed by immunoblotting to demonstrate cellular differentiation (involucrin) and reduced Rad51 or
BRCA1 protein in shRNA-transduced cells. GAPDH was used as a loading control. Fold change in episome copy number was determined by performing
densitometry of episomal bands from four independent experiments using ImageJ software. Shown is the fold change relative to T0 shScram, which is set to 1.
Error bars represent means standard errors. *, P 0.05. WB, Western blot.
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(8, 9). In support of this, multiple components of the ATM
response, in addition to Rad51 and BRCA1, are required for
productive replication, including the MRN complex (Mre11,
Rad50, Nbs1) and Chk2 (4, 32). ATM can stimulate recombi-
nation through two homology-directed pathways: Rad51-de-
pendent strand invasion (referred to as HR) and single-strand
annealing (SSA), both of which rely on a resection intermediate
(49). SSA, which is inhibited by Rad51 assembly on ssDNA, has
recently been implicated in recombination-dependent replica-
tion of HSV-1 (26). The recruitment of Rad51 and BRCA1 to
viral genomes suggests that HPV utilizes ATM activity to repair
replication-associated DSBs through HR. As HR involves the
use of the sister chromatid as a template for repair (50) and is
generally considered an error-free process, HPV may preferen-
tially use this method of repair for high-fidelity genome ampli-
fication upon differentiation. In addition, productive replica-
FIG 5 Cell cycle distribution is not affected by knockdown of Rad51 or BRCA1. CIN612 cells were transduced with control shRNA (shScram) or Rad51
(shRad51) or BRCA1 (shBRCA1) shRNA containing lentiviral particles and either harvested at T0 (undifferentiated) or differentiated in methylcellulose for 24
and 48 h. Cells from each time point were ethanol fixed, stained with propidium iodide (20 g/ml), and analyzed for total cellular DNA content by flow
cytometry. Graphed values are the averages of three independent experiments. Error bars represent means standard errors. Statistics were performed using a
two-tailed t test comparing shScram to shRad51 and shBRCA1 for the G2/M phase at each time point, with a P value of 
0.05. N.S., not significant; MC,
methylcellulose.
FIG 6 Inhibition of Rad51 DNA binding activity leads to a defect in productive replication. (A) Chromatin immunoprecipitation (ChIP) for Rad51 on the
HPV31 upstream regulatory region (URR)was performed inCIN612 cells at time zero (undifferentiated) or after 72 h of differentiation in high-calciummedium
(Ca). Data for ChIP signals (y axis) from three independent experiments were normalized to 1% of input used. Error bars represent means standard errors. *,
P	 0.001. (B) DNA and protein were harvested from CIN612 cells at T0 (undifferentiated), as well as after differentiation in high-calcium medium for 72 h in
the presence of DMSO (DM) or increasing concentrations of the Rad51 inhibitor B02. DMSO was added at a volume equal to that of the 30 M concentration
of B02. DNA was digested with BamHI (noncutter) or HindIII to linearize the viral genome and then analyzed by Southern blotting for effects on viral copy
number using the HPV31 genome as a probe. Western blot analysis was performed to examine the effect of B02 treatment on Rad51 levels and differentiation
(involucrin). (C) Effects on episomal copy number were determined by performing densitometry of episomal bands from three independent experiments using
ImageJ software. Graphed is the average fold change relative toDMSO(DM)–72-hCa,which is set to 1. Error bars representmeans standard errors. *,P	 0.01.
Statistics were assayed using a two-tailed t test. Ca, calcium; WB, Western blot.
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tion is thought to occur in a G2/M-like environment (45), at a
time when HR is most active (45).
End resection is a key step in the choice of DSB repair pathway
utilized, promoting pathways that use homology while suppress-
ing error-proneNHEJ (20). Previous studies fromour lab indicate
that DNA-activated protein kinase (DNA-PK), a key factor in
classic NHEJ, does not localize to viral genomes (8), suggesting
that HR factors are specifically recruited. ATM and BRCA1 each
play essential roles in directing repair through recombination by
initiating resection of DSBs. ATM accomplishes this through
phosphorylation of the endonuclease CtIP (18), while BRCA1 an-
tagonizes the resection inhibitor 53BP1 (51–53) and recruits CtIP
to the MRN resection complex (54–56). We previously demon-
strated that Mre11’s nuclease activity is required for productive
replication and that the localization of Rad51 to HPV31 genomes
in differentiating cells requires an intact MRN complex (32). The
increased binding of Rad51 per viral genome upon differentiation
suggests that MRN-dependent resection may be required for
Rad51 loading on viral DNA. Recent studies by Langsfeld et al.
indicate that Rad51 binding to viral genomes is dependent on the
activity of the Sirtuin 1 deacetylase (57). Interestingly, in previous
studies we found that 53BP1 localization to HPV31 genomes in-
creases upon differentiation (8), which in theory should restrict
HR at viral genomes. However, the requirement of Rad51 and
BRCA1 for productive replication argues against this. Recent
studies have shown that BRCA1 spatially excludes 53BP1 from the
FIG 7 Productive replication is abrogated in HFK-31 cells treated with an inhibitor of Rad51 activity, which reduces HR activity. (A) DNA was harvested from
HFK-31 cells at T0 as well as after differentiation in high-calcium medium for 72 h in the presence of DMSO (DM) or increasing concentrations of the Rad51
inhibitor B02. DMSOwas added at a volume equal to that of the 30Mconcentration of B02. DNAwas digested with BamHI (noncutter) or HindIII to linearize
the viral genome and then analyzed by Southern blotting to examine episome copy number using the HPV31 genome as a probe. Western blot analysis was
performed to examine the effect of B02 treatment on Rad51 levels and differentiation (involucrin). (B) Fold change in episome copy number in response to B02
treatment was determined by performing densitometry of episomal bands from three independent experiments using ImageJ software. Graphed is the average
fold change relative to DMSO (DM)–72-h Ca, which is set to 1. Error bars represent means standard errors. Statistics were assayed using a two-tailed t test. *,
P	 0.01. (C) Schematic of the DR-GFP reporter used to monitor HR activity. SceGFP is a modified GFP gene containing an I-SceI restriction site and in-frame
termination codons. The iGFP fragment can be used to repair the I-SceI-induced DSB through HR, resulting in GFP expression. (D) HFK-31 cells containing a
chromosomally integrated homologous recombination reporter cassette (DR-GFP) were transduced with I-SceI-containing lentivirus particles to induce a DSB
within the DR-GFP reporter cassette. DMSO (DM) or increasing concentrations of B02 were added 24 h after transduction with I-SceI. Forty-eight hours after
addition of B02, cells were fixed and analyzed for GFP expression by flow cytometry as a measurement of HR repair. Shown is the fold change in percent GFP
relative to the untreated (UT) sample. Graphed values are averages of values from five independent experiments, with error bars representingmeans standard
errors. Statistics were assayed using a two-tailed t test. *, P	 0.05. Ca, calcium; WB, Western blot.
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proximity of DSBs during S phase (53). BRCA1 may serve the
same function on HPV genomes during productive replication.
Future studies will focus on determining if and how HPV utilizes
ATM activity and BRCA1 to influence the DSB repair pathway of
choice, as has recently been shown for SV40 (58).
Our studies support a role for HR during productive replica-
tion, potentially for repair of replication-associated DNA breaks.
However, increasing evidence supports a role for HR proteins,
including Rad51, BRCA1, and BRCA2, as well as resection en-
zymes (CtIP andMRN), in replication fork stabilization indepen-
dently of DSB repair (59–64). In response to replication stress,
BRCA1 and BRCA2 stabilize Rad51 at stalled forks, protecting
nascent strands against nucleolytic degradation (59–61). Fork re-
start requires Rad51, which catalyzes Holliday junction formation
by invading a homologousmolecule (65). HPV16 E7 induces rep-
lication stress due to unscheduled entry into the cell cycle, result-
ing in a paucity of nucleotides to support DNA synthesis (66).
Upondifferentiation, E7 pushes postmitotic cells back into the cell
cycle to provide cellular factors required for productive replica-
tion (67). Whether cell cycle reentry upon differentiation also in-
duces replication stress is unclear but could potentially impact
viral genome amplification if cellular substrates are not immedi-
ately available. Alternatively, viral genome amplification could in
itself lead to replication stress due to the high levels of cellular
substrates required to meet the demand for increased viral DNA
synthesis. HPV may utilize ATM activity and HR factors to pre-
serve replication fork integrity, preventing the collapse of replica-
tion forks into DSBs. Understanding how HR factors are utilized
during viral replication will be an important area of future study.
Our studies indicate that the transient loss of Rad51 and
BRCA1 expression does not impact episomal copy number in un-
differentiated cells. Although we cannot rule out a role for these
HR factors in long-term episomal maintenance, these results mir-
ror our previous studies in which inhibition of ATM activity (4),
as well as disruption of theMRNcomplex (32), hadminimal effect
on maintenance replication but was specifically required for pro-
ductive viral replication. Furthermore, our previous studies dem-
onstrated that knockdown of Nbs1 affected only the localization
of Rad51 to viral genomes upon differentiation (32). This may
suggest that in undifferentiated cells, Rad51 is not localized to viral
genomes for repair but may be present at single-stranded DNA
formed through transient uncoupling of the replication fork from
the viral E1 helicase (59, 68). These results also argue that perhaps
there are inherent differences in the way HPV replicates and uti-
lizes DNA repair pathways during different phases of the viral life
cycle. In support of this, Flores and Lambert provided evidence
thatHPV16 andHPV31 undergo a shift in themode of replication
upon differentiation (69). In undifferentiated cells, HPV repli-
cates bidirectionally; however, two-dimensional (2D) gel analysis
revealed that productively replicating genomes exhibit branched
structures, including X structures and simple Y arcs, consistent
with strand invasion (Holliday junction formation) and unidirec-
tional (rolling-circle) replication, respectively (70, 71). These
studies offer support for our findings that recombination is im-
portant for successful viral genome amplification and suggest that
productive replication may occur through rolling-circle replica-
tion and concatemer formation. If viral concatemers are indeed
formed during productive replication, recombination may addi-
tionally be required to resolve concatemers into individual ge-
nomes.
We have found that Rad51 and BRCA1 are increased in
HPV31-positive cells at the level of transcription and protein sta-
bility. Increased levels of Rad51 have been documented in a wide
range of human tumors, including HPV-positive head and neck
cancer cell lines, as well as HPV-positive cervical cancer lines (42,
72). Moreover, increased expression of Rad51 is correlated with
increased genomic instability through an elevation in spontane-
ous and aberrant HR (73, 74). Although we can detect HR activity
in HPV31-positive cell lines using an HR-specific reporter assay,
whether this activity is increased relative to uninfected cells is cur-
rently unclear. How HPV infection affects DSB repair at cellular
sites of damage is also unknown. HPVmay increase expression of
Rad51 and BRCA1 to drive productive replication, but in turn,
this increase could be detrimental to the genomic stability of
HPV-infected cells and contribute to cancer progression. Alterna-
tively, HPV may sequester these factors for viral replication, pre-
ventingHR repair of cellularDSBs, resulting in increased genomic
instability.
Our studies indicate that both HPV31 E6 and E7 are able to
facilitate an increase in Rad51 and BRCA1 transcript levels,
though the mechanism remains unclear. Both Rad51 and BRCA1
are regulated in a manner dependent on E2F transcription factors
(38, 39, 75–77). The ability of E7 to target Rb and the related
pocket proteins p130 and p107 for degradation, in turn resulting
in constitutive activation of E2F transcription factors, may facili-
tate increased expression of Rad51 and BRCA1. E6 has also been
shown to induce expression of E2F-responsive genes (78). In ad-
dition, p53 can repress Rad51 expression (79), and E6’s ability to
promote p53 degradation may account for the increase in Rad51
andBRCA1 transcripts thatwe observed.While E7was also able to
significantly increase Rad51 and BRCA1 protein levels compared
to uninfected HFKs, this was not consistently observed for E6,
despite the increase in Rad51 and BRCA1 transcript levels. These
data suggest an additional level of regulation for the increased
levels of Rad51 and BRCA1 protein observed in HPV-positive
cells. In support of this, we have found that the protein half-life of
Rad51 and BRCA1 is increased in HPV31-positive cells, although
the mechanism is unclear. HPV31 induces an ATM- as well as
ATR-dependent DNA damage response (4), which may in turn
stabilize Rad51 and BRCA1 through phosphorylation (7, 16). In
addition, HPV16 E7 has been shown to bind BRCA1 (80), which
may be sufficient to protect BRCA1 from degradation. Whether
E7 also binds Rad51 is unknown. While HPV16 E6 also interacts
with BRCA1 (80), E6 has been shown to bind to the ubiquitin
ligase HERC2 (81), which can target BRCA1 for degradation (82).
Understanding the regulation of Rad51 and BRCA1 gene expres-
sion and protein stability in HPV-positive cells is an important
area for future study.
In summary, we have demonstrated that Rad51 and BRCA1
are required for productive replication.Wehave found that Rad51
is bound to viral genomes and that Rad51 activity is required for
successful amplification of viral genomes upon differentiation,
suggesting thatHPV replication is driven through recombination.
In addition, we have shown that E7 increases Rad51 and BRCA1
levels in a transcriptional and potentially posttranscriptional
manner. In addition to ensuring cell cycle reentry upon differen-
tiation, E7 may contribute to productive replication by maintain-
ing the expression of repair factors that are required for viral DNA
synthesis.Overall, these studies provide a deeper understanding of
HR Factors Are Required for Productive HPV Replication
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how HPV utilizes the DNA damage response to regulate produc-
tive viral replication.
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